Jae-Min Kim, MD, PhD

  • 4Articles
  • 12.5KReads
  • 2014–2025Active
  • 22Collaborators
  • 82Citations

About

Jae-Min Kim, MD, PhD, is affiliated with the Department of Psychiatry at Chonnam National University Medical School in Gwangju, Republic of Korea. Kim has published extensively on topics including major depressive disorder, delirium, neurology, and posttraumatic stress disorder. Research contributions focus on biomarker differentiation of depression subtypes, early prediction of PTSD, stigma and quality of life after delirium recovery, and escitalopram treatment in depressive disorder following acute coronary syndrome. Kim’s work has appeared in Psychiatrist.com from 2014 to 2025.

Publications

JCP
Differentiating Subtypes of MDD Using Serum Biomarkers
Original Research

Differentiating Subtypes of MDD Using Serum Biomarkers

June 23, 2025

Significant differences in biomarker profiles were observed across MDD subtypes: the melancholic subtype showed higher cortisol levels and lower serotonin levels, and the atypical subtype showed elevated levels of...
, , , et al
JCP
Predictive Validity of Early Post-Injury CAPS-5 Score for Later PTSD Diagnosis
Original Research

Predictive Validity of Early Post-Injury CAPS-5 Score for Later PTSD Diagnosis

August 5, 2024

A CAPS-5 score of ≥15 provided good predictive accuracy for subsequent PTSD development in the general injured population.
, , , et al
JCP
Article

Now You Do, Now You Don' t

August 23, 2017

Patients experiencing delirium and the atypical personality displays that go with it often remember their actions after recovering from their delirious state. This unique study looks at patients' lingering...
, , , et al
JCP
Original Research

Escitalopram Treatment for Depressive Disorder Following Acute Coronary Syndrome: A 24-Week Double-Blind, Placebo-Controlled Trial

October 14, 2014

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe